u/CuraleafSupportTeam

Reddit r/weedstocks
· tracked since Sep 2026
Calls
2
Win Rate
50.0%
return
+3.2%
Calls 2 1 Posts tracked · 0.1/day
Calls
7d 0
30d 2
90d 2
Win Rate 50% Long 1 Short 1
Win Rate
7d 100%
30d
90d
Average Return +3.2% Long Return +6.7% Short Return -0.3%
Average Return
7d +1.7%
30d
90d
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Short
Sep 08
$3.86
-0.3%
Aurora standalone plan weak versus Curaleaf offer
Curaleaf's fact sheet argues Aurora's standalone turnaround plan will not create more value than the acquisition offer. The mechanism is that Aurora's continued ATM issuances at prices below the offer, roughly C$5 billion in impairments and negative operating cash flow since FY21 weaken its standalone equity case. The main risk is that Aurora's board and holders may still reject the offer and the standalone plan could succeed. No explicit time horizon is given.
Tobacco & Nicotine
Long
Sep 08
$13.74
+6.7%
Curaleaf says its Aurora offer beats standalone plan
Curaleaf argues its proposal to acquire Aurora offers a 45% premium (110% excluding Aurora's cash) and that Aurora's standalone turnaround plan will not create more value. The mechanism is that Aurora's continued ATM issuances below the offer price, roughly C$5 billion in impairments and negative operating cash flow since FY21 undermine its standalone case, making the Curaleaf offer the better outcome for Aurora holders. The main stated risk is Aurora's claim that Curaleaf's leverage is a risk and that the US$5.00 cap limits upside. No explicit time horizon is given.
Tobacco & Nicotine
Showing 2 of 2 calls · sorted by mentions

u/CuraleafSupportTeam has 2 trade ideas tracked on Buzzberg across 2 tickers since September 2026. Most covered: ACB, CURA.TO.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology